The two main effective strategies used to prevent or treat hyperuricemia in patients are the use of XO inhibitors, such as allopurinol (AL) and febuxostat, to decrease UA production, and the use of uricosuric agents (e.g., benzbromarone) to increase UA excretion. The gene discussed is XDH; the disease is hyperuricemia.